Quick Answer
PALISADE BIO, INC. reported Total Assets of $134.34 million for fiscal year 2025.
PALISADE BIO, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $134.34M | +1134.8% |
| 2024 | $10.88M | -22.6% |
| 2023 | $14.05M | -10.9% |
| 2022 | $15.76M | +26.0% |
| 2021 | $12.51M | +314.4% |
| 2020 | $3.02M | -54.1% |
| 2019 | $6.58M | -14.3% |
| 2018 | $7.68M | -44.7% |
| 2017 | $13.88M | -38.6% |
| 2016 | $22.60M | +51.2% |
| 2015 | $14.95M | -49.9% |
| 2014 | $29.84M | +53.7% |
| 2013 | $19.41M | +121.9% |
| 2012 | $8.75M | +114.1% |
| 2011 | $4.09M | -61.4% |
| 2010 | $10.59M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.97M | -25.3% | +4.6% |
| June 30, 2025 | $6.67M | -48.2% | -18.6% |
| March 31, 2025 | $8.19M | -35.3% | -24.7% |
| December 31, 2024 | $10.88M | -22.6% | +16.5% |
| September 30, 2024 | $9.34M | -45.3% | -27.5% |
| June 30, 2024 | $12.87M | -29.6% | +1.7% |
| March 31, 2024 | $12.65M | -17.1% | -10.0% |
| December 31, 2023 | $14.05M | -10.9% | -17.7% |
- PALISADE BIO, INC. showed an increase of +1134.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, PALISADE BIO, INC.’s total assets has grown by 1168.4% (from $10.59 million to $134.34 million).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: